Status:
ACTIVE_NOT_RECRUITING
Shockwave Therapy for Plantar Fasciitis RCT
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Plantar Fascitis
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in active or overweight individuals. It can be treated via conservative or surgical therapies. Extracorporeal shoc...
Detailed Description
Plantar fasciitis is a common foot problem that affects 3.8 per 1,000 persons in the United States. It is characterized by inflammation of the plantar fascia, a fibrous tissue which connects the calca...
Eligibility Criteria
Inclusion
- Patients presenting with a clinical diagnosis of chronic plantar fasciitis (\>3 months) that has been recalcitrant to other treatments
- Minimum VAS pain of 40/100 (4/10; morning pain when taking first steps, pain after prolonged walking/standing)
- English-speaking
Exclusion
- Cortisone injection within the past 3 months
- Platelet-rich plasma injection within the past 6 months
- History of previous foot surgery
- Bilateral heel pain
- Coagulopathies or use of anti-coagulants
- Local and systemic neurologic or vascular insufficiencies
- Rheumatologic disorders
- Systemic inflammatory disorders
- Active or chronic infection in the area
- Lower extremity bone disorders (e.g., Paget's disease, osteomyelitis)
- Calcaneal fractures
- Nerve entrapment
- Ruptures in tendon
- Non-English speaking
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2026
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT04332471
Start Date
June 1 2020
End Date
March 1 2026
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021